FBC
AGN

Fairfield, Bush & Co’s Allergan plc AGN Stock Holding History

Fairfield, Bush & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,092
Closed -$208K – 160
2018
Q3 		$208K Buy
+1,092
New +$201K 0.06% 152
2017
Q4 		– Sell
-1,513
Closed -$310K – 163
2017
Q3 		$310K Hold
1,513
– – 0.1% 118
2017
Q2 		$368K Hold
1,513
– – 0.12% 109
2017
Q1 		$361K Sell
1,513
-50
-3% -$11.6K 0.11% 112
2016
Q4 		$328K Sell
1,563
-453
-22% -$93.8K 0.11% 113
2016
Q3 		$464K Sell
2,016
-40
-2% -$9.78K 0.15% 108
2016
Q2 		$475K Buy
2,056
+952
+86% +$219K 0.16% 98
2016
Q1 		$296K Buy
1,104
+357
+48% +$102K 0.11% 106
2015
Q4 		$233K Hold
747
– – 0.08% 132
2015
Q3 		$203K Hold
747
– – 0.09% 121
2015
Q2 		$227K Sell
747
-357
-32% -$106K 0.07% 156
2015
Q1 		$329K Buy
+1,104
New +$315K 0.1% 133

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fairfield, Bush & Co's AGN Position: Q4 2018 in Review

Fairfield, Bush & Co sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 1,092 shares — an estimated $208K sold.

Fairfield, Bush & Co first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $475K in Q2 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Fairfield, Bush & Co reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Fairfield, Bush & Co sold 1,092 Allergan plc shares in Q4 2018, an estimated $208K.
  • Fairfield, Bush & Co first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • Fairfield, Bush & Co's Allergan plc position peaked at $475K in Q2 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Fairfield, Bush & Co's 13F filing for Q4 2018, filed 11 Feb 2019.